Multi-Phase Cross-modal Learning for Noninvasive Gene Mutation
  Prediction in Hepatocellular Carcinoma by Gu, Jiapan et al.
Multi-Phase Cross-modal Learning for Noninvasive Gene Mutation
Prediction in Hepatocellular Carcinoma
Jiapan Gu∗1, Ziyuan Zhao∗1, Zeng Zeng†1, Yuzhe Wang2, Zhengyiren Qiu2, Bharadwaj Veeravalli2
Brian Kim Poh Goh3, Glenn Kunnath Bonney4, Krishnakumar Madhavan4
Chan Wan Ying5, Lim Kheng Choon6, Thng Choon Hua5, and Pierce KH Chow7
Abstract— Hepatocellular carcinoma (HCC) is the most
common type of primary liver cancer and the fourth
most common cause of cancer-related death worldwide.
Understanding the underlying gene mutations in HCC
provides great prognostic value for treatment planning and
targeted therapy. Radiogenomics has revealed an association
between non-invasive imaging features and molecular
genomics. However, imaging feature identification is laborious
and error-prone. In this paper, we propose an end-to-end
deep learning framework for mutation prediction in APOB,
COL11A1 and ATRX genes using multiphasic CT scans.
Considering intra-tumour heterogeneity (ITH) in HCC,
multi-region sampling technology is implemented to generate
the dataset for experiments. Experimental results demonstrate
the effectiveness of the proposed model.
Clinical relevance The proposed framework applied deep
learning and multi-region sampling to predict gene mutations
based on multi-phase 3D CT scans, achieving 75% average
accuracy. The architecture can be implemented to provide
clinical diagnostic and predictive oncology services.
I. INTRODUCTION
Liver cancer is one of the leading causes of cancer-
related deaths in many parts of the world and one of
the most common cancers among males in Singapore [1].
Hepatocellular carcinoma (HCC) is the most common type of
primary liver cancer which is the sixth most common cancer
in the world and the fourth leading cause of cancer mortality
globally [2]. HCC is known to be a highly heterogeneous
disease [3], especially in genetic level, which means the lack
of consistency in the therapeutic outcome and thus may lead
to the difficulty in clinic for designing targeted therapy and
precision medicine. Recent studies have identified several
mutations in genes associated with HCC. For instance,
telomerase reverse transcriptase (TERT) promoter, TP53/p53
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Fig. 1. Illustration of the appearance of tumors in different phases. The
appearance of the tumor and non-tumor (background) in NC and PV phase
is similar. However, the appearance of the tumor and non-tumor is quite
different in ART phase.
and CTNNB1/beta-catenin have been identified as the most
commonly mutated genes in HCC [4].
In general, current methods of genome sequencing require
liver biopsy and specialized equipment, which limit the
routine usage. Besides, these invasive sampling methods are
destructive, and can not provide multiple continuous snap-
shots. Many research work have demonstrated that different
imaging features in computed tomography (CT) scans are
correlated with the global gene expression of primary human
liver cancer, e.g., Segal et al. used 28 features out of over
100 image features manually extracted from CT scans to
reconstruct 78% of the gene expression patterns in HCC
patients [5]. Such an integrated diagnostic approach between
Radiology and Genomics is termed as “radiogenomics” [6].
However, the development of radiogenomics for HCC
is critically impeded by the following challenges. First,
Dynamic CT images are widely used in liver CT scanning.
Multi-phase CT scans are divided into four phases, i.e., non-
contrast (NC) phase, arterial (ART) phase, portal venous
(PV) phase, and delay (DL) phase in Fig. 1. Varying object
sizes, e.g., lesions and tumors make it difficult to obtain com-
prehensive information in dynamic multi-modal images. Sec-
ond, there is intra-tumour heterogeneity (ITH) in HCC [7],
which means gene mutations are different in different parts of
tumors. This scenario makes machine learning approaches,
especially convolutional neural network (CNN) very difficult
to train for gene mutation prediction in HCC, as the input
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slices of the whole tumor with different gene mutations
are assigned the same mutation label. Third, radiogenomics
requires quantitative imaging features annotated by expert
radiologists, which is laborious, time-consuming and suffers
from high intra / inter-observer variance.
In this work, we propose a deep CNN framework to
address the challenges of automatic gene mutation prediction
in HCC. More specifically, a multi-stream CNN is applied for
multi-phase cross-modal feature extraction followed by an
aggregation layer to effectively fuse and utilize 4D informa-
tion. Besides, some image traits (biomarkers) [8] identified
by radiologists are aggregated as auxiliary information for
decision making. Extensive experiments are implemented on
the dataset collected from different hospitals in Singapore,
in which, multi-region sampling is applied to avoid mis-
match problems in ITH. Experimental results and analysis
demonstrate the effectiveness of the proposed framework for
mutation prediction in APOB, COL11A1, and ATRX genes,
which is easily implemented to predict more gene mutations
if sufficient data are provided.
II. RELATED WORK
A. Radiogenomics and AI
As a rapidly developing field, radiogenomics has shown
potential value for diagnostic and therapeutic strategies. In
the fields of radiomics and radiogenomics, high-throughput
extraction of qualitative and quantitative imaging features
from radiographs is required to obtain diagnostic, predictive,
or prognostic information [9]. To explore the relationships
between gene expression and imaging, Segal et al. [5]
defined ‘units of distinctiveness’, termed as ‘traits’ from
qualitative imaging features of liver cancer and reconstructed
nearly 80% of the global gene expression profiles using 28
image traits. Aerts et al. [10] proposed a quantitative strategy
for the correlation between CT images and genome data,
which reflects great clinical significance. These contribute to
the development of emerging technologies such as computer
vision and deep learning in radiogenomics [11], [12]. The use
of artificial intelligence (AI) for genomics and molecular pro-
filing of cancers will be hugely beneficial as it is non-invasive
and captures a comprehensive view of the tumor. However,
most of the current radiogenomics analysis in liver cancer
extracted image features from single-phase images which did
not consider the changes of shapes and sizes of tumors across
phases. Besides, merging multiphasic information remains a
critical issue.
B. Multi-region Sampling
Genomic profiling methods behind most of the current
radiogenomics analysis rely on single biopsy samples, which
often reflects a part of the tumor. These methods significantly
underestimate intratumoral genomic heterogeneity in cancers
especially in HCC. A large proportion of HCC displays a
clear geographic segregation where spatially closer sectors
are genetically more similar [7]. Furthermore, this genetic
heterogeneity in HCC influences the training process of
CNNs. Slices with different mutations are put into networks
Fig. 2. Multi-region sampling for genomics. (A) Tumor and sectors are
annotated on the CT scan. (B) Resected tumor with annotated orientation.
(C) Multi-region sampling of tumor over the central slice with annotated
sectors. (D) Illustration of multi-region sampling and obtaining samples for
the omics levels of analysis in PLANET 1. PDP and PDX refer to patient-
derived progenitor cells and patient-derived xenografts respectively.
with the same mutation label, which misleads the training
process of networks. Zhai et al. [7] first carried out research
on intra-tumour heterogeneity (ITH) in HCC using multi-
region sampling. As shown in Fig. 2, first, tumor and sectors
were annotated on the CT scans. Then a central slice is cut
from the patient tumor, and a linear grid of tumor sectors is
then harvested and examined for further multiomics analysis.
The dataset used in this work adopted multi-region sampling.
III. METHODOLOGY
The proposed method for gene mutation prediction is il-
lustrated in Fig. 3, which consists of three main components:
(i) Multi-stream Feature Extraction, (ii) Feature Aggrega-
tion, and (iii) Auxiliary Embedding. First, the processed
images from different phases are put into four deep CNN
blocks separately for feature extraction; then a lightweight
CNN is applied to fuse multi-stream information for further
prediction [13]. For better prediction, biomarkers annotated
by doctors are embedded into the network as auxiliary
information to improve the prediction accuracy.
In multi-stream feature extraction, Residual Neural Net-
work (ResNet) [14], [15] is implemented for deep feature
extraction, in which some layers are skipped through shortcut
connection to avoid the vanishing gradient problem. The 3D
ResNet-18 pre-trained on ImageNet [16] is applied.
In feature aggregation, feature maps from four streams
are combined by concatenation along the channel dimension,
followed by a shallow network including one convolution
layer (512, 1 × 1 × 1), one batch normalization layer, and
one ReLU activation layer for dimensionality reduction in
the channel dimension space.
Compared to using images only, some image traits
(biomarkers) are embedded into the final fully connected
1More details of multi-omics discovery platform PLANET are shown in:
https://www.nccs.com.sg/research-innovation/research-programmes/disease-
focus-liver
Fig. 3. Overall framework of the proposed method, the processed images from different phases are trained using four separate 3D CNN (3D ResNet-18),
followed by concatenation and a shadow CNN block. The biomarkers are embedded with image features for final prediction on gene mutation.
layer. These image traits are the characteristics described
by radiologists, which can be regarded as indicators of
physiologic and pathologic processes in response to various
diagnostic or therapeutic procedures. In our experiments,
nine kinds of biomarkers are annotated as binary variables
by doctors, such as “presence of intra-tumoral vessels”. More
details can be found in Fig. 5. These biomarkers are treated
as a series of binary numbers followed by a fully connected
layer with a size of 128. The output of the fully connected
layer is combined with image features for further prediction.
Binary cross-entropy is used as the loss function for the
binary classification problem.
IV. EXPERIMENTS
A. Dataset and implementation
The dataset has been collected from multiple hospitals
located in Singapore, which consists of 3D multiphasic CT
scans, genomics information and biomarker sequences from
27 patients with the approval of the Institutional Review
Board. Due to various sources of data, 14 patients with all
four phases were considered in our experiments. The DNA
sequencing was based on multi-region sampling, in which,
gene mutations are different from different sectors of the
tumor, therefore, our training samples are on the basis of
the sector rather than patient. The ground truth mutation
labels were extracted from the DNA sequencing, and the
corresponding sectors were extracted from the patients’ CT
scans. Because of various sizes of sectors, the sectors were
padded with zeros to keep the same size in length and width,
and five adjacent slices along z-axis based on the central slice
of sector were cropped from volumetric images to probe the
spatial information along the third dimension, see Fig. 4.
Typically, HCC in different regions of the liver is clinically
scored on the basis of their CT image features, such as size
and margin. Therefore, nine biomarkers were annotated by
radiologists based on CT scans.
Because of data imbalance in different gene mutations,
prevalent mutated genes, i.e., APOB, COL11A1 and ATRX
Fig. 4. Image preprocessing pipeline: first, five continuous slices of the
same sectors are extracted, and then, the regions of the sectors are cropped
from the original slices followed by padding with zeros, keeping the same
size in length and width.
are considered in this study. Given that the mutations are
not mutually exclusive, a separate model per mutation is
used to alleviate the problem of data imbalance among muta-
tions. We compare our model with single-stream CNN using
single-phase CT scans, in which, ResNet-18 is trained on
images from one of the four phases, e.g., Single Stream (ART
phase). To explore the effectiveness of auxiliary embedding
in the proposed architecture, the proposed model without
biomarkers is also implemented, i.e., Proposed (without
biomarkers). To validate the stability of the proposed model,
leave-one-out cross validation (LOOCV) is performed, in
which, each patient is excluded from the training set one
at a time and then classified on the basis of the predictor
built from the data for all the other patients.
TABLE I
AUTOMATIC GENE MUTATION PREDICTION PERFORMANCE OF
DIFFERENT METHODS.
Methods AccuracyAPOB COL11A1 ATRX
Single Stream (NC phase) 58.9% 51.3% 60.1%
Single Stream (ART phase) 70.1% 55.5% 57.5%
Single Stream (PV phase) 64.1% 56.4% 68.1%
Single Stream (DL phase) 68.4% 56.9% 64.5%
Proposed (without biomarkers) 77.3% 67.7% 73.4%
Proposed 76.7% 71.7% 76.5%
B. Results and discussion
Table I summarizes the results of all methods on the
dataset. The proposed method outperforms all other methods
in different gene mutations, which demonstrates the effec-
tiveness of feature fusion cross phases. Besides, biomarkers
can help to improve the accuracy of mutation prediction
in COL11A1 and ATRX, which proves the feasibility of
biomarkers in radiogenomics analysis.
To further explore the correlations among biomarkers and
gene mutations, a correlation map is generated with the
whole dataset, as shown in Fig. 5. We find that most of these
biomarkers are correlated with gene mutations. Furthermore,
some gene mutations are correlated with each other. We
performed hierarchical clustering of the correlation map and
found that some gene mutations are grouped into the same
cluster, therefore, the complex relationships among gene
mutations can be modeled using graph neural networks for
prediction in the future [17].
Fig. 5. Correlation map and hierarchical clustering based on pairwise
Pearson correlation coefficients of biomarkers and gene mutations. Some
gene mutations are correlated (red) or anti-correlated (blue).
V. CONCLUSIONS AND FUTURE WORK
In this work, we discuss the challenges and standard-of-
care imaging technologies in HCC radiogenomics analysis.
Considering the intra-tumour heterogeneity (ITH) in HCC,
we propose a sector-based multi-stream cross-modal deep
learning framework for mutation prediction in genes. Mul-
tiphasic CT scans are processed and extracted by multi-
stream CNN followed by feature aggregation. Moreover, the
biomarkers are embedded into the final layer for further
prediction. Experimental results on the dataset show the
effectiveness of the proposed framework on mutation pre-
diction in APOB, COL11A1, and ATRX genes. However,
our framework is extendable to more gene mutations with
sufficient training data. The correlation between the gene
mutations and biomarkers not only validate the predictive
value of biomarkers, but also show the significant correla-
tions among different gene mutations. In our future work,
the relationships between gene mutations will be analyzed
and considered as predictor variables.
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